Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000932471-25-000291·IRONWOOD PHARMACEUTICALS INC
Schedule 13G ownership disclosure
Ironwood Pharmaceuticals Inc
Common Stock · CUSIP: 46333X108
Event date: 2024-12-31
- Filing-level shares
- 19,538,555
- Percent of class
- 12.2%
- The Vanguard Group
Shares: 19,538,555 · Class: 12.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000291
- Form type
- SCHEDULE 13G/A
- Filer
- IRONWOOD PHARMACEUTICALS INC
- CIK
- CIK 1446847
- Filed
- Jan 31, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership